Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapies for multiple myeloma.

Joseph D Tariman1

  • 1Northwestern University Medical Faculty Foundation, Chicago, IL 60611, USA. jtariman@u.washington.edu

Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society
|April 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action.

Journal of the advanced practitioner in oncology·2025
Same author

Multiple Myeloma: Validation of the Values and Preferences Elicitation Questionnaire- Cure and Survival Preference Scale (VPEQ-CSPS).

Clinical lymphoma, myeloma & leukemia·2024
Same author

Cultural Competence of Student Registered Nurse Anesthetists in Illinois.

AANA journal·2021
Same author

Stress and Coping: A Literature Review of Everyday Stressors and Strategies to Cope in Pediatric Patients With Cancer.

Clinical journal of oncology nursing·2021
Same author

Examining effective communication in nursing practice during COVID-19: A large-scale qualitative study.

International nursing review·2021
Same author

How to Prevent Endotracheal Tube Cuff Overinflation: "5 for 25".

AANA journal·2021

Multiple myeloma, a B-cell cancer, is incurable yet treatable. This overview covers current therapies, focusing on bortezomib and lenalidomide, and nursing care for side effects.

Area of Science:

  • Oncology
  • Hematology
  • Pharmacology

Background:

  • Multiple myeloma is a B-cell malignancy involving plasma cells.
  • While incurable, it is a highly treatable condition.
  • Understanding current treatment landscapes is crucial for patient management.

Purpose of the Study:

  • To provide an overview of multiple myeloma.
  • To discuss current therapeutic strategies, including novel agents.
  • To highlight nursing considerations for managing treatment-related adverse events.

Main Methods:

  • Literature review of multiple myeloma and its treatments.
  • Focus on bortezomib and lenalidomide mechanisms and efficacy.
  • Discussion of adverse event management and nursing implications.

Related Experiment Videos

Main Results:

  • Multiple myeloma remains a significant hematologic malignancy.
  • Bortezomib and lenalidomide represent key therapeutic options.
  • Effective management of adverse events is essential for patient care.

Conclusions:

  • Multiple myeloma requires comprehensive management strategies.
  • Targeted therapies like bortezomib and lenalidomide improve outcomes.
  • Nursing vigilance is critical for optimizing patient safety and treatment adherence.